Crossref
How to Improve Complex Drug Development? A Critical Review of FDA Advisory Meetings
Drug Information Journal · 2007-09 · 41 (5) · 673-684
DOI: 10.1177/009286150704100514 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Information Journal, online erschienen am 30.12.2007. Verfasst von Pol F. Boudes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Boudes, P. F. (2007). How to Improve Complex Drug Development? A Critical Review of FDA Advisory Meetings. Drug Information Journal, 41(5), 673-684. https://doi.org/10.1177/009286150704100514
Vancouver
Boudes PF. How to Improve Complex Drug Development? A Critical Review of FDA Advisory Meetings. Drug Information Journal. 2007;41(5):673-684. doi:10.1177/009286150704100514
BibTeX
@article{Boudes2007,
author = {Boudes, Pol F.},
title = {How to Improve Complex Drug Development? A Critical Review of FDA Advisory Meetings},
journal = {Drug Information Journal},
year = {2007},
volume = {41},
number = {5},
pages = {673--684},
doi = {10.1177/009286150704100514}
}
EUVIMED